Table 5 Attitudes towards the implementation of a measurement system of infections in ICUs
Weighted estimates for Europe (respondents from 16 countries with >=10 replies) | Other respondants (66 countries) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N=1281 | N=449 | |||||||||||
Agree strongly/ agree | Disagree/ disagree strongly | Agree strongly/ agree | Disagree/ disagree strongly | |||||||||
% | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |||||
To what extent do you agree with the following comments | ||||||||||||
If you cannot measure it, you cannot improve it | 83 | 80 | 85 | 11 | 9 | 13 | 84 | 80 | 87 | 11 | 8 | 14 |
Monitoring of VAP related measures stimulates quality improvement | 93 | 91 | 94 | 2 | 1 | 3 | 97 | 94 | 98 | 1 | 0 | 3 |
VAP-related measures in my ICU (if any) are reliable | 54 | 51 | 58 | 12 | 10 | 15 | 66 | 61 | 70 | 8 | 6 | 11 |
I am willing to implement, or support, a VAP data collection system | 84 | 81 | 86 | 4 | 3 | 6 | 92 | 89 | 94 | 1 | 0 | 3 |
Clinical diagnosis of VAP is difficult: this makes measurement systems unreliable | 46 | 43 | 50 | 32 | 29 | 36 | 43 | 38 | 47 | 36 | 32 | 41 |
There is a difference between a definition of VAP for reporting, and a diagnosis of VAP for treatment | 45 | 42 | 49 | 32 | 28 | 35 | 46 | 41 | 50 | 30 | 26 | 35 |
Please indicate what actions would facilitate the implementation of a measurement system of infections in ICUs | ||||||||||||
Timely feed-back of data at ICU level | 92 | 90 | 94 | 1 | 1 | 2 | 96 | 93 | 97 | 0 | 0 | 2 |
Administrative support | 88 | 86 | 90 | 2 | 1 | 3 | 95 | 92 | 97 | 1 | 0 | 2 |
Dedicated software / IT resources | 91 | 89 | 93 | 2 | 1 | 3 | 92 | 89 | 94 | 0 | 0 | 2 |
Reliable data | 95 | 93 | 96 | 1 | 0 | 2 | 96 | 94 | 98 | 0 | 0 | 1 |